NEMAURA MEDICAL INC.: 10-Q filed 2020-02-10

Name: NEMAURA MEDICAL INC.: 10-Q filed 2020-02-10
Creator: NEMAURA MEDICAL INC.

What NEMAURA MEDICAL INC. reported in its quarterly report filed 2020-02-10 (fiscal Q3 2020): 34 published measures, 95 facts as tagged in accession 0001079973-20-000094.

This filing

Form: 10-Q (quarterly report)
Filed: 2020-02-10
Fiscal period: fiscal Q3 2020
Accession: 0001079973-20-000094 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NEMAURA MEDICAL INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2019-12-31	2,163,628	USD
At 2019-03-31	4,763,715	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2019-12-31	2,398,156	USD
At 2019-03-31	2,536,811	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2019-12-31	-234,528	USD
At 2019-09-30	196,313	USD
At 2019-03-31	2,226,904	USD
At 2018-12-31	3,156,430	USD
At 2018-09-30	2,050,446	USD
At 2018-03-31	4,110,965	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2019-12-31	1,067,663	USD
At 2019-03-31	3,740,664	USD
At 2018-12-31	5,040,661	USD
At 2018-03-31	822,335	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2019-10-01 to 2019-12-31	-445,007	USD	92
2019-04-01 to 2019-12-31	-2,813,312	USD	275
2018-10-01 to 2018-12-31	-925,889	USD	92
2018-04-01 to 2018-12-31	-2,828,318	USD	275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2019-04-01 to 2019-12-31	-2,563,963	USD	275
2018-04-01 to 2018-12-31	-2,318,366	USD	275

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2019-04-01 to 2019-12-31	162,615	USD	275
2018-04-01 to 2018-12-31	43,216	USD	275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Unit	Days
2019-10-01 to 2019-12-31	USD	92
2019-04-01 to 2019-12-31	USD	275
2018-10-01 to 2018-12-31	USD	92
2018-04-01 to 2018-12-31	USD	275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2019-04-01 to 2019-12-31	140,710	USD	275
2018-04-01 to 2018-12-31	2,135,646	USD	275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2019-04-01 to 2019-12-31	-213,185	USD	275
2018-04-01 to 2018-12-31	4,412,090	USD	275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2019-12-31	-16,239,191	USD
At 2019-03-31	-13,425,879	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2019-10-01 to 2019-12-31	20,808,050	shares	92
2019-04-01 to 2019-12-31	20,798,013	shares	275
2018-10-01 to 2018-12-31	20,540,709	shares	92
2018-04-01 to 2018-12-31	17,217,952	shares	275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2019-10-01 to 2019-12-31	-614,362	USD	92
2019-04-01 to 2019-12-31	-614,362	USD	275
2018-10-01 to 2018-12-31	0	USD	92
2018-04-01 to 2018-12-31	0	USD	275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2019-12-31	192,264	USD
At 2019-03-31	56,871	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2019-04-01 to 2019-12-31	317,664	USD	275
2018-04-01 to 2018-12-31	183,667	USD	275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2019-10-01 to 2019-12-31	-1,059,369	USD	92
2019-04-01 to 2019-12-31	-3,431,600	USD	275
2018-10-01 to 2018-12-31	-932,925	USD	92
2018-04-01 to 2018-12-31	-2,852,245	USD	275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2019-12-31	1,741,380	USD
At 2019-03-31	4,515,160	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2019-12-31	1,143,206	USD
At 2019-03-31	1,298,961	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2019-12-31	183,757	USD
At 2019-03-31	161,348	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2019-12-31	229,984	USD
At 2019-03-31	191,684	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2019-10-01 to 2019-12-31	1,059,369	USD	92
2019-04-01 to 2019-12-31	3,431,600	USD	275
2018-10-01 to 2018-12-31	932,925	USD	92
2018-04-01 to 2018-12-31	2,852,245	USD	275

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2019-12-31	229,894	USD
At 2019-03-31	38,036	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2019-10-01 to 2019-12-31	516,672	USD	92
2019-04-01 to 2019-12-31	1,535,370	USD	275
2018-10-01 to 2018-12-31	443,380	USD	92
2018-04-01 to 2018-12-31	1,495,201	USD	275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit
At 2019-12-31	20,808,348	shares
At 2019-03-31	20,765,592	shares
At 2018-03-31	6,767,600	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2019-12-31	-388,874	USD
At 2019-03-31	-339,888	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2019-12-31	-234,528	USD
At 2019-03-31	2,226,904	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2019-12-31	422,248	USD
At 2019-03-31	248,555	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2019-10-01 to 2019-12-31	-470,841	USD	92
2019-04-01 to 2019-12-31	-2,862,298	USD	275
2018-10-01 to 2018-12-31	-964,515	USD	92
2018-04-01 to 2018-12-31	-3,140,036	USD	275

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2019-10-01 to 2019-12-31	-445,007	USD	92
2019-04-01 to 2019-12-31	-2,813,312	USD	275
2018-10-01 to 2018-12-31	-925,889	USD	92
2018-04-01 to 2018-12-31	-2,828,318	USD	275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2019-10-01 to 2019-12-31	542,697	USD	92
2019-04-01 to 2019-12-31	1,896,230	USD	275
2018-10-01 to 2018-12-31	489,545	USD	92
2018-04-01 to 2018-12-31	1,357,044	USD	275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2019-04-01 to 2019-12-31	47,550	USD	275
2018-04-01 to 2018-12-31	21,924	USD	275

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2019-04-01 to 2019-12-31	152,492	USD	275
2018-04-01 to 2018-12-31	455,105	USD	275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2019-04-01 to 2019-12-31	186,137	USD	275
2018-04-01 to 2018-12-31	0	USD	275

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2019-04-01 to 2019-12-31	21,259	USD	275
2018-04-01 to 2018-12-31	155,286	USD	275

Inspect the source

Entity: NEMAURA MEDICAL INC. / CIK 0001602078
Captured: 2026-09-22 19:51 UTC
SEC response SHA-256: 3af4f00449f095884d927b68ab2fc6d79dd5add77d667bb50f3822178e742afd

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001602078.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))